Monzosertib

DB21619InvestigationalSmall molecule

Monzosertib is a small molecule drug. The usage of the INN stem '-sertib' in the name indicates that Monzosertib is a serine/threonine kinase inhibitor. Monzosertib has a monoisotopic molecular weight...

Formula / weight: C₂₁H₂₂F₃N₅O₄ · 465.433 g/mol (avg)

Resolves to

Compound

UNIIHOY1L711NLCAS1402057-88-8ChEMBLCHEMBL4868568

Structure

InChIKeyDNTVXDZWVOVLOD-GDNBJRDFSA-NSMILESCCOC(=O)C1=C(NN2CCN(CC(F)(F)F)CC2)O\C(=C/C2=CNC3=NC=CC=C23)C1=O

What you can answer from here — as of September 13, 2026

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Monzosertib, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account